.jpg)
The two-day gathering (October 17–18) has brought together over 500 doctors, scientists, and patient advocates from across India and abroad to explore advancements in regenerative medicine and neurorestoratology.
Shri Jual Oram, Minister of Tribal Affairs, inaugurated the conference, emphasizing the transformative role of scientific innovation in healthcare. Speaking at the event, he announced plans to urge Prime Minister Narendra Modi to consider including cellular therapies for Divyang patients under the Ayushman Bharat scheme, aiming to make these life-changing treatments accessible to all.
Health Minister Shri J.P. Nadda extended greetings via video message, noting India’s rising global prominence in stem cell and cellular therapy research. “This conference serves as a platform to merge scientific insight, clinical expertise, and policy guidance, inspiring young professionals while offering real solutions to patients with neurological and orthopedic disorders,” he said.
Focus on Cellular Therapies for Neurological and Orthopedic Conditions
The conference emphasizes cellular therapies, which repair damaged tissues and enhance functional recovery in patients with complex conditions. Delegates highlighted the potential benefits for over 2.68 crore Divyang citizens in India, stressing that these therapies could dramatically improve the lives of patients previously deemed untreatable. India currently leads globally in scientific publications related to neurological disorders.
Dr. Alok Sharma of the Society of Regenerative Sciences stated, “Our work is pioneering treatments for patients with no alternatives. India has emerged as a global leader, thanks to PM Modi’s support for stem cell research and international collaborations. Inclusion of cellular therapies under Ayushman Bharat would make these treatments widely accessible.”
Dr. Hongyun Huang, Founding President of IANR, added, “With continued research and international cooperation, we aim to restore neurological function, improve cardiac rhythm, and elevate overall patient well-being. India is now ahead of China in regenerative medicine capabilities.”
Experts from the USA, China, Poland, South Korea, Argentina, Hong Kong, and other countries attended. Day one featured discussions on neurorestoration trends, stem cell interventions, and policy frameworks to support regenerative medicine in India. Dr. Alok Sharma was also nominated as IANR President for 2025.
Doctors and patient representatives jointly appealed for the inclusion of cellular therapies for neurological, orthopedic, and other incurable conditions under Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), advocating affordable access for all patients.
The conference continues tomorrow (October 18), featuring thematic sessions, expert panels, and international presentations focused on clinical translation and policy development in regenerative and restorative medicine.
.jpg)
.jpg)
